- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07701694
Functional Evaluation in Patients With Urea Cycle Disorders (UCD) During a Driving Task
Cognitive and Motor Function Examination in Patients With Urea Cycle Disorders (UCD) During a Driving Task Using Functional Near Infrared Spectroscopy (fNIRS)
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Primary Objective
- To use fNIRS to study brain functional behavior in subjects with UCD by measuring the changes in HbO, HbR and HbT concentrations versus healthy control volunteers during the baseline driving task on the left and right prefrontal cortex (LPFC, RPFC).
Secondary Objective
- To include other cortical regions such as temporal and occipital regions, to investigate the neurocognitive changes in these regions which may or may not change with driving. Thus, we will measure changes in HbO, HbR and HbT concentrations during the baseline driving task in four more brain regions (left and right parietal and occipital regions, LPA, RPA, LOL, ROL).
This is a non-therapeutic, non-interventional study in which brain fNIRS (functional near-infrared spectroscopy) measures will be compared under simulated driving conditions between patients with UCD vs. age and sex-matched control participants.
Participants who agree to participate will have Information about their medical history collected, have a basic neurological exam and answer questions about their health, diet, and driving habits. They will complete some simple thinking and memory tests. These tests will help investigators understand skills like memory, attention, and problem-solving. Participants will also wear a soft cap with small sensors called an fNIRS (functional near-infrared spectroscopy) device while they complete a driving simulator activity. This cap is noninvasive and measures how the brain uses oxygen while they drive in the simulator.
All study activities will be completed on the day of enrollment.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Jean Laboe, RN
- Numéro de téléphone: 901-595-1693
- E-mail: jean.laboe@stjude.org
Lieux d'étude
-
-
Tennessee
-
Memphis, Tennessee, États-Unis, 38105
- Recrutement
- St. Jude Children's Research Hospital
-
Contact:
- Jean Laboe, RN
- Numéro de téléphone: 901-595-1693
- E-mail: jean.laboe@stjude.org
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Individuals 16 to 40 years with molecular or biochemical confirmation of a urea cycle disorder.
- Healthy individuals will serve as an age and sex matched comparison group. Active driver's license for at least 6 months
- Read and understand English. as the tasks have not been validated in other languages
- IQ >=70.
Exclusion Criteria:
- Skin disease that affects the scalp
- Past or present vascular disease
- Head trauma with loss of consciousness in the last year or evidence of cognitive impairment due to and persisting after head trauma
- Motor movement disorder which may cause excessive movement or impede use of the steering wheel and/or pedal
- Premature birth or birth before 32 weeks of gestation
- The participant is taking a stimulant or antidepressant
- Allergy to any component of the device, although expected to be rare
- History of psychosis
- Self-reported motion or cyber sickness
- Self-reported illicit substance use
- Vision disorder
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
|---|
|
UCD group
Participants with urea cycle disorders (UCD) who meet the Eligibility Criteria and consent to participate
|
|
Control group
Healthy controls who meet the Eligibility Criteria and consent to participate
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Changes in Oxyhemoglobin (HbO), Deoxyhemoglobin (HbR) and Total Hemoglobin (HbT) concentrations in the right and left prefrontal cortex in participants with urea cycle disorders (UCD) compared to healthy control volunteers
Délai: Day 1, during driving simulator task
|
Investigators will compare prefrontal cortex hemoglobin concentrations during low cognitive load between patients with UCD and healthy age and sex matched control participants using functional near-infrared spectroscopy (fNIRS).
Mean values of hemoglobin concentration differences on the right and left prefrontal cortex between individuals, with and without UCD, during the low cognitive load task will be calculated and compared using two sample t-tests (for normally distributed data) or Wilcoxon rank sum tests (for nonnormally distributed data).
P values will be adjusted for multiple comparisons using the Bonferroni method.
|
Day 1, during driving simulator task
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Changes in HbO, HbR and HbT concentrations in the left and right parietal and occipital brain regions in participants with urea cycle disorders (UCD) compared to healthy control volunteers
Délai: Day 1, during driving simulator task
|
Investigators will compare left and right parietal and occipital regions hemoglobin concentrations during low cognitive load between patients with UCD and healthy age and sex matched control participants using functional near-infrared spectroscopy (fNIRS).
Mean values of hemoglobin concentration differences on the left and right parietal and occipital regions between individuals, with and without UCD, during the low cognitive load task will be calculated and compared using two sample t-tests (for normally distributed data) or Wilcoxon rank sum tests (for nonnormally distributed data).
P values will be adjusted for multiple comparisons using the Bonferroni method.
|
Day 1, during driving simulator task
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Andrea Gropman, M.D., St. Jude Children's Research Hospital
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Maladies du cerveau
- Maladies du système nerveux central
- Maladies du système nerveux
- Métabolisme, erreurs innées
- Maladies génétiques, innées
- Maladies métaboliques
- Maladies cérébrales, métaboliques, innées
- Maladies cérébrales métaboliques
- Métabolisme des acides aminés, erreurs innées
- Maladies et anomalies congénitales, héréditaires et néonatales
- Maladies nutritionnelles et métaboliques
- Troubles du cycle de l'urée, innés
Autres numéros d'identification d'étude
- DRIVEUCD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .